- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Most Popular Stocks
Global Pharmaceuticals & Biotech Most Popular Stocks
Results
3043
Most Popular Stocks on the market
3043 companies
BGI Genomics
Market Cap: CN¥18.7b
Provides genomic sequencing and proteomic services in China and internationally.
300676
CN¥48.75
7D
-3.8%
1Y
20.8%
SK bioscienceLtd
Market Cap: ₩3.7t
Engages in the research and development, production, and distribution of vaccines and biopharmaceuticals in Korea and internationally.
A302440
₩46,800.00
7D
-5.4%
1Y
-16.6%
Hybio Pharmaceutical
Market Cap: CN¥18.5b
Engages in the development, manufacture, and commercialization of therapeutic peptides API and peptide-based drugs in China and internationally.
300199
CN¥20.96
7D
-13.2%
1Y
100.6%
Amicus Therapeutics
Market Cap: US$2.6b
A biotechnology company, focuses on discovering, developing, and delivering novel medicines for rare diseases in the United States and internationally.
FOLD
US$8.32
7D
-1.9%
1Y
-22.4%
Veracyte
Market Cap: US$2.6b
Operates as a diagnostics company in the United States and internationally.
VCYT
US$32.82
7D
-1.2%
1Y
-2.1%
Shenzhen Kangtai Biological Products
Market Cap: CN¥18.3b
Shenzhen Kangtai Biological Products Co., Ltd.
300601
CN¥16.42
7D
-4.4%
1Y
-2.8%
Walvax Biotechnology
Market Cap: CN¥18.3b
Engages in the research and development, manufacture, and distribution of vaccines in China.
300142
CN¥11.45
7D
-3.9%
1Y
-6.7%
InventisBio
Market Cap: CN¥18.2b
A clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States.
688382
CN¥31.45
7D
-7.3%
1Y
273.5%
Pfizer
Market Cap: ₹225.6b
Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.
PFIZER
₹4,931.00
7D
-3.5%
1Y
-15.4%
Everest Medicines
Market Cap: HK$19.4b
A biopharmaceutical company, engages in the discovery, license-in, development, and commercialization of therapies and vaccines to address critical unmet medical needs in Greater China and other Asia Pacific markets.
1952
HK$54.95
7D
-4.9%
1Y
113.4%
AstraZeneca Pharma India
Market Cap: ₹220.5b
A biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
506820
₹8,819.10
7D
-1.3%
1Y
22.7%
Bausch Health Companies
Market Cap: US$2.5b
Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.
BHC
US$6.46
7D
-6.2%
1Y
-20.3%
Guangzhou Innogen Pharmaceutical Group
Market Cap: HK$19.1b
Engages in development of drugs.
2591
HK$41.84
7D
-0.6%
1Y
n/a
Wockhardt
Market Cap: ₹217.2b
Operates as a pharmaceutical and biotech company, in India, the United States, the United Kingdom, Switzerland, Ireland, Russia, Europe, and internationally.
WOCKPHARMA
₹1,336.50
7D
-11.2%
1Y
35.6%
Eris Lifesciences
Market Cap: ₹216.0b
Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.
ERIS
₹1,585.50
7D
-3.3%
1Y
25.1%
Haw Par
Market Cap: S$3.2b
Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.
H02
S$14.23
7D
-3.1%
1Y
30.9%
Ab&B Bio-Tech JS
Market Cap: HK$18.9b
Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.
2627
HK$47.96
7D
-5.1%
1Y
n/a
Aspen Pharmacare Holdings
Market Cap: R42.3b
Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.
APN
R96.00
7D
-5.8%
1Y
-50.8%
Catalyst Pharmaceuticals
Market Cap: US$2.4b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$19.13
7D
-6.2%
1Y
-4.1%
Nanjing King-Friend Biochemical PharmaceuticalLtd
Market Cap: CN¥17.0b
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
603707
CN¥10.55
7D
-2.0%
1Y
-22.2%
Tecan Group
Market Cap: CHF 1.9b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 149.40
7D
-5.7%
1Y
-45.8%
ImmunityBio
Market Cap: US$2.4b
A commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases.
IBRX
US$2.46
7D
-13.7%
1Y
-36.9%
Shanghai Haoyuan Chemexpress
Market Cap: CN¥16.8b
Researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs.
688131
CN¥79.22
7D
7.4%
1Y
183.5%
Yifan Pharmaceutical
Market Cap: CN¥16.7b
Engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally.
002019
CN¥13.75
7D
-3.4%
1Y
18.3%
Anhui Anke Biotechnology (Group)
Market Cap: CN¥16.7b
Anhui Anke Biotechnology (Group) Co., Ltd.
300009
CN¥10.01
7D
-2.9%
1Y
14.7%
Zhejiang Jiuzhou Pharmaceutical
Market Cap: CN¥16.7b
Operates as contract development and manufacturing organization company in China and internationally.
603456
CN¥18.93
7D
-2.2%
1Y
30.9%
Tarsus Pharmaceuticals
Market Cap: US$2.3b
A commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States.
TARS
US$55.39
7D
2.5%
1Y
67.1%
Beam Therapeutics
Market Cap: US$2.3b
A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.
BEAM
US$23.09
7D
-8.0%
1Y
-8.1%
Fujian Cosunter Pharmaceutical
Market Cap: CN¥16.5b
Engages in the research and development, manufacture, and sale of pharmaceutical products in China.
300436
CN¥103.60
7D
-4.1%
1Y
415.9%
OneSource Specialty Pharma
Market Cap: ₹205.0b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally.
ONESOURCE
₹1,789.80
7D
-2.8%
1Y
n/a
AddLife
Market Cap: SEK 21.9b
Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 180.60
7D
-5.5%
1Y
11.5%
Belite Bio
Market Cap: US$2.3b
A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States.
BLTE
US$70.01
7D
-4.4%
1Y
49.4%
Celcuity
Market Cap: US$2.3b
A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
CELC
US$51.94
7D
-5.6%
1Y
264.7%
Zhejiang Jingxin Pharmaceutical
Market Cap: CN¥16.3b
Zhejiang Jingxin Pharmaceutical Co., Ltd.
002020
CN¥19.98
7D
-1.5%
1Y
70.0%
Staidson (Beijing) BioPharmaceuticals
Market Cap: CN¥16.2b
Staidson (Beijing) BioPharmaceuticals Co., Ltd.
300204
CN¥33.87
7D
-4.6%
1Y
385.9%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥16.1b
Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China.
300573
CN¥65.60
7D
-4.3%
1Y
1.5%